{"id":"https://openalex.org/W7065129836","doi":null,"title":"Diabetes mellitus tipo 2 e suas complica\u00e7\u00f5es - associa\u00e7\u00e3o com novos marcadores inflamat\u00f3rios e moleculares","display_name":"Diabetes mellitus tipo 2 e suas complica\u00e7\u00f5es - associa\u00e7\u00e3o com novos marcadores inflamat\u00f3rios e moleculares","publication_year":2017,"publication_date":"2017-04-06","ids":{"openalex":"https://openalex.org/W7065129836"},"language":"pt","primary_location":{"id":"pmh:oai:repositorio.ufmg.br:1843/58018","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/1843/58018","pdf_url":"https://repositorio.ufmg.br/bitstreams/8233fd39-1555-4be6-9d7b-5a3fc5301245/download","source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"instacron:UFMG","raw_type":"info:eu-repo/semantics/doctoralThesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://repositorio.ufmg.br/bitstreams/8233fd39-1555-4be6-9d7b-5a3fc5301245/download","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108420332","display_name":"Kathryna Fontana Rodrigues","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Kathryna Fontana Rodrigues","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5108420332"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11142","display_name":"Advanced Glycation End Products research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":1.0},{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.6489999890327454},{"id":"https://openalex.org/keywords/microvascular-complications","display_name":"microvascular complications","score":0.9259999990463257},{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.9700000286102295},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.7770000100135803},{"id":"https://openalex.org/keywords/irisin","display_name":"irisin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/haptoglobin","display_name":"haptoglobin","score":0.9860000014305115},{"id":"https://openalex.org/keywords/visfatin","display_name":"visfatin","score":0.7279999852180481},{"id":"https://openalex.org/keywords/circulating-microparticles","display_name":"circulating microparticles","score":0.777999997138977},{"id":"https://openalex.org/keywords/endocan","display_name":"endocan","score":0.8870000243186951},{"id":"https://openalex.org/keywords/il-10-polymorphism","display_name":"IL-10 polymorphism","score":0.8510000109672546},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.6470000147819519},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.7329999804496765},{"id":"https://openalex.org/keywords/endothelial-dysfunction","display_name":"endothelial dysfunction","score":0.7929999828338623},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.890999972820282},{"id":"https://openalex.org/keywords/adipokines","display_name":"adipokines","score":0.9629999995231628}],"concepts":[{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.7903000116348267},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.6541000008583069},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.6274999976158142},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5931000113487244},{"id":"https://openalex.org/C206396517","wikidata":"https://www.wikidata.org/wiki/Q422025","display_name":"Haptoglobin","level":2,"score":0.5687999725341797},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5547999739646912},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.5440000295639038},{"id":"https://openalex.org/C2780972559","wikidata":"https://www.wikidata.org/wiki/Q550061","display_name":"Endothelial dysfunction","level":2,"score":0.5051000118255615},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.49709999561309814},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47909998893737793},{"id":"https://openalex.org/C113280763","wikidata":"https://www.wikidata.org/wiki/Q2326546","display_name":"Subclinical infection","level":2,"score":0.4641000032424927},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4641000032424927},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4268999993801117},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4212000072002411},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4198000133037567},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.4196000099182129},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4020000100135803},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.3393999934196472},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.322299987077713},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.32179999351501465},{"id":"https://openalex.org/C67636389","wikidata":"https://www.wikidata.org/wiki/Q784237","display_name":"Genetic predisposition","level":3,"score":0.3203999996185303},{"id":"https://openalex.org/C149737253","wikidata":"https://www.wikidata.org/wiki/Q3240252","display_name":"Polymorphism (computer science)","level":4,"score":0.31119999289512634},{"id":"https://openalex.org/C76252995","wikidata":"https://www.wikidata.org/wiki/Q3395645","display_name":"Gene polymorphism","level":4,"score":0.3057999908924103},{"id":"https://openalex.org/C2776782570","wikidata":"https://www.wikidata.org/wiki/Q357439","display_name":"Adiponectin","level":4,"score":0.3034000098705292},{"id":"https://openalex.org/C171089720","wikidata":"https://www.wikidata.org/wiki/Q193583","display_name":"Adipose tissue","level":2,"score":0.2838999927043915},{"id":"https://openalex.org/C2776513394","wikidata":"https://www.wikidata.org/wiki/Q1412400","display_name":"Microangiopathy","level":3,"score":0.2831000089645386},{"id":"https://openalex.org/C146304588","wikidata":"https://www.wikidata.org/wiki/Q961652","display_name":"Case-control study","level":2,"score":0.28279998898506165},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2653999924659729},{"id":"https://openalex.org/C190789776","wikidata":"https://www.wikidata.org/wiki/Q767511","display_name":"Genetic marker","level":3,"score":0.2639999985694885},{"id":"https://openalex.org/C186413461","wikidata":"https://www.wikidata.org/wiki/Q744727","display_name":"Genetic association","level":5,"score":0.25049999356269836},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2500999867916107}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:repositorio.ufmg.br:1843/58018","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/1843/58018","pdf_url":"https://repositorio.ufmg.br/bitstreams/8233fd39-1555-4be6-9d7b-5a3fc5301245/download","source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"instacron:UFMG","raw_type":"info:eu-repo/semantics/doctoralThesis"}],"best_oa_location":{"id":"pmh:oai:repositorio.ufmg.br:1843/58018","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/1843/58018","pdf_url":"https://repositorio.ufmg.br/bitstreams/8233fd39-1555-4be6-9d7b-5a3fc5301245/download","source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"instacron:UFMG","raw_type":"info:eu-repo/semantics/doctoralThesis"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320321091","display_name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","ror":"https://ror.org/00x0ma614"},{"id":"https://openalex.org/F4320322025","display_name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","ror":"https://ror.org/03swz6y49"},{"id":"https://openalex.org/F4320322980","display_name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","ror":"https://ror.org/00nc55f03"},{"id":"https://openalex.org/F4320324369","display_name":"Universidade Federal de Minas Gerais","ror":"https://ror.org/0176yjw32"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7065129836.pdf","grobid_xml":"https://content.openalex.org/works/W7065129836.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2051182630","https://openalex.org/W2151726082","https://openalex.org/W4311416754","https://openalex.org/W7127153117","https://openalex.org/W7151829440","https://openalex.org/W2023863507","https://openalex.org/W4206531285","https://openalex.org/W7098632341","https://openalex.org/W4410489313","https://openalex.org/W7136510952"],"abstract_inverted_index":{"Type":[0],"2":[1],"diabetes":[2,11],"mellitus":[3],"(T2DM)":[4],"is":[5],"the":[6,43,71,88,196,204,243,254,265],"most":[7],"prevalent":[8],"form":[9],"of":[10,15,21,26,42,54,82,90,110,164,172,195,247],"mellitus,":[12],"a":[13,35,170,209],"disease":[14],"epidemic":[16],"proportions":[17],"that":[18,73,123,216],"affects":[19],"millions":[20],"people":[22],"worldwide.":[23],"The":[24,80,120],"pathogenesis":[25,255],"T2DM":[27,111,124,205,226,248],"and":[28,46,57,61,78,92,101,107,112,131,138,147,182,207,218,227,235,245,257],"its":[29,98],"microvascular":[30,99],"complications":[31,100],"are":[32,159,223],"associated":[33],"with":[34,96,105],"chronic":[36],"subclinical":[37],"inflammation,":[38],"characterized":[39],"by":[40,232],"activation":[41,220],"immune":[44],"system":[45],"intracellular":[47],"inflammatory":[48,55,94],"signaling":[49],"pathways,":[50],"altered":[51,224],"expression/secretion":[52],"pattern":[53],"mediators":[56],"adipokines,":[58],"endothelial":[59,136],"dysfunction":[60],"oxidative":[62],"stress.":[63],"Visceral":[64],"obesity":[65,173,233],"plays":[66],"an":[67],"important":[68],"role":[69],"in":[70,75,161,179,191,203,225],"events":[72],"culminate":[74],"insulin":[76],"resistance":[77],"T2DM.":[79,192],"objective":[81],"this":[83],"research":[84],"was":[85,175,200],"to":[86,153,177,252,263],"evaluate":[87],"association":[89],"biochemical":[91,217],"molecular":[93],"markers":[95,221,241],"T2DM,":[97],"comorbidities.":[102],"102":[103],"patients":[104,125],"clinical":[106,266],"laboratory":[108],"diagnosis":[109],"62":[113],"non-diabetic":[114,154],"controls":[115],"where":[116],"selected":[117],"for":[118],"participation.":[119],"results":[121,214],"indicated":[122],"had":[126],"higher":[127],"IL-6,":[128,180],"irisin,":[129,181],"haptoglobin,":[130],"circulating":[132],"microparticles":[133,140],"levels":[134,150,158,190,222],"(platelet-,":[135],"cells-":[137],"leukocytes-derived":[139],"as":[141,143,259],"well":[142,260],"tissue":[144],"factor":[145],"carriers);":[146],"lower":[148],"endocan":[149],"when":[151],"compared":[152],"controls.":[155],"Furthermore,":[156],"visfatin":[157],"decreased":[160],"advanced":[162],"stages":[163],"diabetic":[165],"nephropathy.":[166],"Body":[167],"mass":[168],"index,":[169],"marker":[171],"status,":[174],"shown":[176],"influence":[178,242],"haptoglobin":[183,197],"levels.":[184],"IL-10":[185,189],"-819T/C":[186],"polymorphism":[187,199],"affected":[188],"Hp1-Hp1":[193],"genotype":[194],"gene":[198],"more":[201],"frequent":[202],"group":[206],"presented":[208],"dominant":[210],"inheritance":[211],"pattern.":[212],"These":[213],"indicate":[215],"cellular":[219],"they":[228],"can":[229],"be":[230,250],"influenced":[231],"status":[234],"genetic":[236],"polymorphisms.":[237],"Understanding":[238],"how":[239],"these":[240],"onset":[244],"development":[246],"may":[249,258],"useful":[251],"elucidate":[253],"mechanisms":[256],"provide":[261],"insights":[262],"ameliorate":[264],"follow-up.":[267]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2025-10-10T00:00:00"}
